William Chase on Abbott's M&A strategy - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

William Chase on Abbott's M&A strategy

Published November 19, 2012 at 1:04 PM


William Chase, Abbott Laboratories' vice president of licensing and acquisitions, and The Deal Pipeline's Ben Fidler discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. - George White

Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Kilpatrick Townsend & Stockton LLP added Vanessa Tollis to its New York office as a partner to chair the international tax practice. For other updates launch today's Movers & shakers slideshow.

Video

Activist investing: What to expect from this year's proxy season

What's likely to happen during the coming proxy season is the subject of Paula Schaap's interview with Damien Park, founder and managing partner of Hedge Fund Solutions, an adviser to funds and corporations on issues related to activism. More video

Sectors